As weary Americans hold out hope that the decline of Omicron signals an end to the pandemic’s emergency phase, physicians who treat long COVID are worried about the potential for a new wave of cases.
More
The SARS-CoV-2 Omicron variant’s “milder” outcomes are likely due to more population immunity rather than the virus’ properties, according to a paper by William Hanage, associate professor of epidemiology at Harvard T.H. Chan School of Public Health, and Roby Bhattacharyya, assistant professor
More
With Omicron’s surge peaking in some U.S. states, experts this week sounded a wary note of optimism that better times are weeks to months away, but they warn that prospects of an “end” are murky, with the likeliest scenario being one in
More
British Reporter — An additional “booster” dose of Moderna or Pfizer mRNA-based vaccine is needed to provide immunity against the Omicron variant of SARS-CoV-2, the virus that causes COVID-19, according to a study by researchers at the Ragon Institute of MGH, MIT
More
Vaccines shown to induce lower levels of neutralising antibodies against Omicron coronavirus variant
British Reporter — Researchers used blood samples collected from Com-COV2 study participants who had received two doses of standard COVID-19 vaccination schedules to perform neutralisation assays using Omicron virus isolate
More
Harvard experts warn of a “surge upon a surge” in COVID-19 infections in the coming weeks, as cases involving the Omicron variant pile onto the nationwide illness and death the Delta strain has left in its wake in recent months.
More
Countries around the world are making preparations against omicron, a new variant of the novel coronavirus that causes COVID-19. On Wednesday, Dec. 1, omicron’s presence in California was confirmed by the U.S. Centers for Disease Control and Prevention.
More
British Reporter — On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). This decision was based on the evidence presented to the TAG-VE that
More